← FDA Drug Approvals (Drugs@FDA)

DIFLUNISAL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS · Approved 1997-07-17

Drug application

FDA Application #

ANDA074400

Application type

Abbreviated New Drug Application (Generic)

Brand name

DIFLUNISAL

Generic name

Diflunisal

Active ingredients

DIFLUNISAL

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

WATSON LABS

First approval

1997-07-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown